Glucose stimulates α-MSH release from the pituitary.
Systemic α-MSH drives glucose disposal and thermogenesis in skeletal muscles.
α-MSH acts on MC5R expressed on skeletal muscles and activate cAMP-PKA pathway.
The combined treatment of nonselective or selective PDE 4 inhibitor and α-MSH ameliorates glucose intolerance in obese mice.